Publications

Sort by: Date | Author | Title

Kharfan-Dabaja, M. A., Kumar, A., Ayala, E., Hamadani, M., Reimer, P., Gisselbrecht, C., d'Amore, F., Jantunen, E., Ishida, T., Bazarbachi, A., Foss, F., Advani, R., Fenske, T. S., Lazarus, H. M., Friedberg, J. W., Aljurf, M., Sokol, L., Tobinai, K., Tse, E. ... Savani, B. N. (2017). Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T-Cell and NK/T-Cell Lymphomas: an International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 23(11), 1826-1838. https://doi.org/10.1016/j.bbmt.2017.07.027
Bouska, A., Zhang, W., Gong, Q., Iqbal, J., Scuto, A., Vose, J., Ludvigsen, M., Fu, K., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Rosenwald, A., Ott, G., Campo, E., Rimsza, L. M., Delabie, J., Jaffe, E. S., Braziel, R. M., Connors, J. M. ... Chan, W. C. (2017). Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia, 31(1), 83-91. https://doi.org/10.1038/leu.2016.175
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Ketterling, R. P., Bedroske, P. P., Luoma, I. M., Sattler, C. A., Boddicker, R. L., Bennani, N. N., Nørgaard, P., Møller, M. B., Steiniche, T., d'Amore, F. & Feldman, A. L. (2017). DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study. Blood, 130(4), 554-557. https://doi.org/10.1182/blood-2016-12-755496
Leivonen, S.-K., Icay, K., Jäntti, K., Siren, I., Liu, C., Alkodsi, A., Cervera, A., Ludvigsen, M., Hamilton-Dutoit, S. J., d'Amore, F., Karjalainen-Lindsberg, M.-L., Delabie, J., Holte, H., Lehtonen, R., Hautaniemi, S. & Leppä, S. (2017). MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma. Blood Cancer Journal, 7(12), 654. Article 654. https://doi.org/10.1038/s41408-017-0033-8
Chan, F. C., Mottok, A., Gerrie, A. S., Power, M., Nijland, M., Diepstra, A., van den Berg, A., Kamper, P., d'Amore, F., d'Amore, A. L., Hamilton-Dutoit, S., Savage, K. J., Shah, S. P., Connors, J. M., Gascoyne, R. D., Scott, D. W. & Steidl, C. (2017). Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma. Journal of Clinical Oncology, 35(32), 3722-3733. https://doi.org/10.1200/JCO.2017.72.7925
Johnson, P., Federico, M., Kirkwood, A. A., Fossa, A., Berkahn, L., Carella, A., d'Amore, F., Enblad, G., Franceschetto, A., Fulham, M. J., Luminari, S., O'Doherty, M. J., Patrick, P., Roberts, T. H., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. N. ... Barrington, S. (2016). Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. The New England Journal of Medicine, 374(25), 2419-2429. https://doi.org/10.1056/NEJMoa1510093
Kim, S. J., Yoon, D. H., Jaccard, A., Chng, W. J., Lim, S. T., Hong, H., Park, Y., Chang, K. M., Maeda, Y., Ishida, F., Shin, D.-Y., Kim, J. S., Jeong, S. H., Yang, D.-H., Jo, J.-C., Lee, G.-W., Choi, C. W., Lee, W.-S., Chen, T.-Y. ... Kim, W. S. (2016). A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncology, 17(3), 389-400. https://doi.org/10.1016/S1470-2045(15)00533-1
Zinzani, P. L., Karlin, L., Radford, J., Caballero, D., Fields, P., Chamuleau, M. E. D., d'Amore, F., Haioun, C., Thieblemont, C., González-Barca, E., Grande García, C., Johnson, P. W., van Imhoff, G. W., Ng, T., Dwyer, K. & Morschhauser, F. (2016). European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. Haematologica, 101(10), e407-e410. https://doi.org/10.3324/haematol.2016.146977
D'Amore, F. A., Relander, T., Lauritzen, G. F., Jantunen, E., Mannisto, S., Meyer, P., Ellin, F., Pedersen, M. B. & Toldbod, H. (2016). Hematopoietic stem-cell transplantation in peripheral T-cell lymphomas. In Hematopoietic cell transplants - Concepts, controversies and future directions (Vol. 37, pp. 343-347). Cambridge University Press. https://doi.org/10.3760/cma.j.issn.0253-2727.2016.04.020
Barrington, S. F., Kirkwood, A. A., Franceschetto, A., Fulham, M. J., Roberts, T. H., Almquist, H., Brun, E., Hjorthaug, K., Viney, Z. N., Pike, L. C., Federico, M., Luminari, S., Radford, J., Trotman, J., Fosså, A., Berkahn, L., Molin, D., D'Amore, F., Sinclair, D. A. ... Johnson, P. W. (2016). PET-CT for staging & early response: results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) (CRUK/07/033). Blood, 127(12), 1531-1538. https://doi.org/10.1182/blood-2015-11-679407
Lugtenburg, PJ., Brown, P. D. N., Van der Holt, B., D'Amore, F. A., Koene, HR., Berenschot, HW., Fijnheer, R., Loosveld, O., Bohmer, LH., Pruijt, H., Verhoef, G., Hoogendoorn, M., de Kan, R., Van Imhoff, GW., van Hooije, C., Lam, KH., de Keizer, B., de Jong, D., Hoekstra, OS. & Zijlstra, JM. (2016). Randomized phase III study on the effect of early intensification of Rituximab in combination with 2-weekly CHOP chemotherapy flollowed by Rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group Study. Abstract from ASCO Annual Meeting, United States.
Agostinelli, C., Gallamini, A., Stracqualursi, L., Agati, P., Tripodo, C., Fuligni, F., Sista, M. T., Fanti, S., Biggi, A., Vitolo, U., Rigacci, L., Merli, F., Patti, C., Romano, A., Levis, A., Trentin, L., Stelitano, C., Borra, A., Piccaluga, P. P. ... Pileri, S. A. (2016). The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study. The Lancet Haematology, 3(10), e467-e479. https://doi.org/10.1016/S2352-3026(16)30108-9
Johnson, PWM., Federico, M., Kirkwood, AA., Fossa, A., Berkahn, L., Carella, AM., D'Amore, F. A., Enblad, G., Franceschetto, A., Fulham, M., Luminari, S., O'Doherty, M., Patrick, P., Roberts, T., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. ... Barrington, SF. (2016). Treatment adaptation guided by interim PET scan in advanced Hodgkin lymphoma. The New England Journal of Medicine, 374(25), 2419-29. https://doi.org/10.1056/NEJMoa1510093.
Ristolainen, H., Kilpivaara, O., Kamper, P., Taskinen, M., Saarinen, S., Leppä, S., d'Amore, F. & Aaltonen, L. A. (2015). Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing. British Journal of Haematology, 170(3), 428-431. https://doi.org/10.1111/bjh.13295
Ristolainen, H., Kilpivaara, O., Kamper, P., Taskinen, M., Saarinen, S., Leppä, S., D'Amore, F. A. & Aaltonen, L. (2015). Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma by exome sequencing. British Journal of Haematology, 170(3), 428-31.
Madsen, C., Pedersen, M. B., Vase, M. Ø., Segel, E. K., Bendix, K., Jensen, BA., Møller, M. B., Johansen, P., Munksgaard, L., Brown, P. D. N. & D'Amore, F. A. (2015). outcome determinats for transformed indolent lymphomas treated with or without autologous stem cell transplantation. Annals of Oncology, 26(2), 393-399.
d'Amore, F., Gaulard, P., Trümper, L., Corradini, P., Kim, W.-S., Specht, L., Bjerregaard Pedersen, M., Ladetto, M. & ESMO Guidelines Committee (2015). Peripheral T-cell Lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 26 Suppl 5, v108-15. https://doi.org/10.1093/annonc/mdv201